NICE Unable To Recommend Golimumab For Psoriatic Arthritis - Wall Street Journal

NICE Unable To Recommend Golimumab For Psoriatic Arthritis Wall Street Journal ... of active and progressive psoriatic arthritis in adults when the response to previous disease-modifying anti-rheumatic drug therapy has been inadequate. ... NHS regulator to reject psoriatic arthritis drug golimumabWebMD.Boots.com UK Cost Watchdog Rejects New BiologicMedPage Today British cost body rebuffs J&J's Simponi drugLondon South East all 7 news articles »

The Symptoms and Treatment Options for Psoriatic Arthritis - EmpowHer

TopNews United Kingdom

The Symptoms and Treatment Options for Psoriatic Arthritis EmpowHer For those suffering from psoriasis, a serious condition of the skin, there exists the potential to develop psoriatic arthritis. ... Arthritis sufferers finally granted new treatmentTopNews United Kingdom all 6 news articles »

Surveyed Dermatologists and Rheumatologists Expect to Increase Their First ... - PR Newswire (press release)

Surveyed Dermatologists and Rheumatologists Expect to Increase Their First ... PR Newswire (press release) According to the new report entitled Treatment Algorithms in Psoriatic Arthritis, Simponi's favorable (once per month) dosing compared with other TNF-alpha ... and more »

Arthritis Sufferers Finally Granted Second Treatment Option - Voxy

Voxy	Arthritis Sufferers Finally Granted Second Treatment Option Voxy Arthritis New Zealand welcomes PHARMAC's announcement that a second biologic option for patients in New Zealand with severe Psoriatic Arthritis (PA), ... and more »